PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 2.43.
| Share Price | ₹162.2 | Feb 26,2026 |
| Market Cap | ₹21,553.0 Cr | |
| Sales-TTM | ₹8,871.4 Cr | TTM-Consolidated Results |
| Price/Sales | 2.43x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹21,553.0 Cr] as on Feb 26,2026
(/) Sales [ ₹8,871.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.43x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.43 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.30x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 1.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2025 at 3.25x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PIRAMAL PHARMA | 8,871.4 | 2.43 | 21,553.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.54 | 428,185.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.65 | 171,766.0 |
| CIPLA LTD | 28,351.1 | 3.87 | 109,680.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.69 | 148,923.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.17 | 110,081.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.76 | 94,121.6 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.62 | 94,399.8 |
| LUPIN LTD | 26,150.5 | 4.06 | 106,180.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.14 | 70,974.0 |
| ABBOTT INDIA LTD | 6,824.1 | 8.20 | 55,961.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.14x |
| Max industry PS | 16.65x |
| Median industry PS | 4.06x |
| Average industry PS | 6.38x |
You may also like the below Video Courses